Express Pharma

Aleor Dermaceuticals receives US FDA final approval for Docosanol cream

Docosanol Cream, 10% (OTC) is used for cold sore/fever blisters on the face or lips

2 150

Alembic Pharma today announced that its wholly owned subsidiary, Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Docosanol cream, 10% (OTC).

The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Abreva Cream, 10% (OTC), of GlaxoSmithKline Consumer Healthcare. Docosanol Cream, 10% (OTC) is used for cold sore/fever blisters on the face or lips, Alembic Pharma said in a statement.

Docosanol Cream, 10% (OTC) has an estimated market size of $60 million for twelve months ending December 2021, according to IQVIA, the statement added.

2 Comments
  1. ferahtia.Fs says

    Nice topic thank you

  2. ferahtia.Fs says

    Merci pour Les information

Leave A Reply

Your email address will not be published.